Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2010-2019
Title
Created Date
The Di Bella Method improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck
02 June 2026
Recurrent Glioblastoma Multiforme (grade IV - WHO 2007): a case of complete objective response - concomitant administration of Somatostatin/Octreotide, Retinoids, Vit E, Vit D3, Vit C, Melatonin, D2 R agonists (Di Bella Method - DBM) associated with Temol
01 June 2026
The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer
29 May 2026
The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature
28 May 2026
Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report
28 May 2026
Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast
27 May 2026
The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer
26 May 2026
Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies
28 April 2026
Melatonin and its therapeutic prospects in gastroenterology
27 April 2026
Melatonin protects against arsenic trioxide-induced liver injury by the upregulation of Nrf2 expression through the activation of PI3K/AKT pathway
22 April 2026
Display #
5
10
15
20
25
30
50
100
All
Page 2 of 173
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Search
Follow us...
Latest
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
The impact of vitamin D on cancer: A mini review
Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
Somatostatin and Somatostatin Receptors in Tumour Biology
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
Programmed cell death and melatonin: A comprehensive review
Beneficial properties of melatonin in an experimental model of pancreatic cancer
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
How effective is chemo therapy?
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Vademecum
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer